Symptom-Based Screening Tool Successfully Identifies Young Children with High Asthma Risk

November 10, 2022

The tool successfully identified children with high asthma risk as young as 3 years of age. The screening tool was found to be more accurate at predicting asthma, persistent wheezing, and related emergency room visits and hospitalizations than standard screening and diagnostic tools.

Cost Effectiveness Analysis of Biomarkers for Guiding Asthma Treatment in Children

August 02, 2022

Using biomarkers for tailoring asthma treatment can reduce the frequency of asthma exacerbations. Some recent results suggest that eosinophil-guided asthma management is associated with lower annual costs than FeNO-guided management.